Latest Adolescent Health News

19Oct
2023

Lesbian & Gay Teens Have Twice the Odds for Binge-Eating Disorders

Lesbian & Gay Teens Have Twice the Odds for Binge-Eating DisordersTHURSDAY, Oct. 19, 2023 (HealthDay News) -- Stigma can take a toll on lesbian, gay and bisexual teens, leading to high rates of binge-eating disorders, researchers say.Compared to their non-LGBTQ peers, lesbian, gay and bisexual teens are more than twice as likely to report binge eating, according to a new study.Bullying, discrimination and stigma because of sexual orientation can be stressors that lead to poor self-esteem and disordered eating, explained lead study author Dr. Jason Nagata. He is an associate professor of pediatrics at the University of California, San Francisco. “Binge eating can result in psychological effects like depression and anxiety, and long-term physical health problems, including diabetes and heart disease,” Nagata added in a university news release....

Dementia Diagnosis Takes Huge Toll on a Family's Finances

18 October 2023
Dementia Diagnosis Takes Huge Toll on a Family`s FinancesWEDNESDAY, Oct. 18, 2023 (HealthDay News) -- Dementia can take a big bite out of an American's bank account, robbing 60% of a patient's net worth in the eight years after a diagnosis, a new study says.The average dementia patient will also see a doubling of out-of-pocket health care expenses in those first eight years, said researchers who studied thousands of seniors with and without the brain disorder.“We found a profound diverge in the financial status between two [patient] scenarios: one with dementia onset and one without the onset,” said study lead author HwaJung Choi. She’s a research associate professor with the University of Michigan's School of Medicine and School of Public Health.“The magnitude and timing of the divergence are indeed surprising to us,” added Choi,...

FDA Proposes Ban on Formaldehyde in Hair Straighteners...

18 October 2023
FDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health DangersWEDNESDAY, Oct. 18, 2023 (HealthDay News) -- The U.S. Food and Drug Administration has proposed a ban on the use of formaldehyde in hair relaxers over concerns about its link to respiratory problems and certain cancers.Right now, the FDA only discourages using such hair-straightening products, which are typically used by Black women.Recent research has helped raise awareness about the potential dangers of using chemical hair relaxers.“We know that these products are very poorly regulated by the federal government in terms of what goes in there,” said Kimberly Bertrand, an associate professor of medicine at Boston University School of Medicine and the lead author of a recently published study on the dangers of relaxers. “You can’t look at an ingredient label and know that it...

Could a Warming Climate Bring Yellow Fever to America?

18 October 2023
Could a Warming Climate Bring Yellow Fever to America?WEDNESDAY, Oct. 18, 2023 (HealthDay News) -- Yellow fever may be resurfacing in the United States, thanks to climate change.The mosquito-borne viral illness decimated southern U.S. cities from 1820 to 1905, and now a new report says it could return to those areas.One of the potential reasons for a yellow fever resurgence? Global warming, because mosquitoes love warm, wet weather.Exactly where yellow fever may turn up in the United States is not known, but historically outbreaks occur in the southern U.S. along ports such as New Orleans, Galveston, Texas, and along the Mississippi River, said study author Dr. Peter Hotez. He is the dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine...

Commonly Used Drug Might Be New Treatment Option for IBS

18 October 2023
Commonly Used Drug Might Be New Treatment Option for IBSWEDNESDAY, Oct. 18, 2023 (HealthDay News) -- An inexpensive medication long used for depression and migraines now has a clinical trial to back up its off-label use for another condition that lowers quality of life: irritable bowel syndrome (IBS).In the study, British researchers found that those taking amitriptyline were almost twice as likely as those taking a placebo to see an improvement in IBS symptoms.“We were delighted that the drug was both effective and safe for IBS when used at a low dose and titrated [slowly increased],” said Dr. Alexander Ford, a professor of gastroenterology at Leeds Institute of Medical Research at St. James's at the University of Leeds.About 1 in 20 people worldwide live with the abdominal pain and bowel issues that are hallmarks of IBS, a chronic...
RSS
123578910Last
HealthDay

Copyright © 2018 HealthDay. All rights reserved.